BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3559921)

  • 1. Pharmacokinetics of morphine and its surrogates. VIII: Naloxone and naloxone conjugate pharmacokinetics in dogs as a function of dose and as affected by simultaneously administered morphine.
    Garrett ER; Shyu WC; Ulubelen A
    J Pharm Sci; 1986 Dec; 75(12):1127-36. PubMed ID: 3559921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of morphine and its surrogates V: Naltrexone and naltrexone conjugate pharmacokinetics in the dog as a function of dose.
    Garrett ER; el-Koussi A el-D
    J Pharm Sci; 1985 Jan; 74(1):50-6. PubMed ID: 3981418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of morphine and its surrogates. VII: High-performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogs.
    Garrett ER; Derendorf H; Mattha AG
    J Pharm Sci; 1985 Nov; 74(11):1203-14. PubMed ID: 4087182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of morphine and its surrogates. III: Morphine and morphine 3-monoglucuronide pharmacokinetics in the dog as a function of dose.
    Garrett ER; Jackson AJ
    J Pharm Sci; 1979 Jun; 68(6):753-71. PubMed ID: 458581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of morphine and its surrogates. X: Analyses and pharmacokinetics of buprenorphine in dogs.
    Garrett ER; Chandran VR
    Biopharm Drug Dispos; 1990; 11(4):311-50. PubMed ID: 2340348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of morphine and its surrogates. XI: Effect of simultaneously administered naltrexone and morphine on the pharmacokinetics and pharmacodynamics of each in the dog.
    Langguth P; Khan PJ; Garrett ER
    Biopharm Drug Dispos; 1990 Jul; 11(5):419-44. PubMed ID: 2207296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of morphine and its surrogates IV: Pharmacokinetics of heroin and its derived metabolites in dogs.
    Garrett ER; Gürkan T
    J Pharm Sci; 1980 Oct; 69(10):1116-34. PubMed ID: 7420276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.
    Garrett ER; Hunt CA
    J Pharm Sci; 1977 Mar; 66(3):395-407. PubMed ID: 845807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.
    Berkowitz BA
    Clin Pharmacokinet; 1976; 1(3):219-30. PubMed ID: 13957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.
    Hasselström J; Säwe J
    Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioanalyses and pharmacokinetics of nafronyl in the dog.
    Garrett ER
    J Pharm Sci; 1984 May; 73(5):635-49. PubMed ID: 6737238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of route of administration and biliary excretion on the pharmacokinetics of isotretinoin in the dog.
    Cotler S; Chen S; Macasieb T; Colburn WA
    Drug Metab Dispos; 1984; 12(2):143-7. PubMed ID: 6144477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats.
    Ouellet DM; Pollack GM
    Drug Metab Dispos; 1995 Apr; 23(4):478-84. PubMed ID: 7600915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intracarotid administration of morphine and naloxone on plasma vasopressin levels and blood pressure in the dog.
    Rockhold RW; Crofton JT; Wang BC; Share L
    J Pharmacol Exp Ther; 1983 Feb; 224(2):386-90. PubMed ID: 6822963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine.
    Misra AL; Pontani RB; Vadlamani NL; Mulé SJ
    J Pharmacol Exp Ther; 1976 Feb; 196(2):257-68. PubMed ID: 1255476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterohepatic recirculation and renal metabolism of morphine in the rat.
    Horton TL; Pollack GM
    J Pharm Sci; 1991 Dec; 80(12):1147-52. PubMed ID: 1815073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation mechanism of guinea pig liver-mediated reduction of naloxone by morphine.
    Kumagai Y; Todaka T; Yamano S; Toki S
    Drug Metab Dispos; 1990; 18(4):462-6. PubMed ID: 1976068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the enterohepatic circulation of morphine in the rat.
    Walsh CT; Levine RR
    J Pharmacol Exp Ther; 1975 Nov; 195(2):303-10. PubMed ID: 1185599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.